Survey - Can we engineer live bacteria to treat cancer?
Type of activity: Survey
Organised by: University College London
Time commitment: One off 10-minute survey
Payment and Expenses: No
Closing date: Saturday 31 December
Researchers at University College London (UCL) are interested in hearing your views on engineered live bacteria in medicine, particularly cancer treatment. Your views will help researchers design new innovative anti-cancer treatments that target the bacteria living on and around tumours to improve patient outcomes with current cancer therapies.
Using live bacteria as drugs is not a new idea but there is now the technology to programme live bacteria to carry out specific jobs e.g. making anti-cancer drugs, or killing bacteria that cause harm, these programmed bacteria are known as live biotherapeutic products.
The purpose of this survey is to understand what you think about using engineered bacteria in cancer treatment. The survey contains multiple choice questions and free text boxes for you to share your views.
The results of the survey will be used to guide research currently investigating the role of engineered bacteria in cancer.
Anyone over 18 years of age can get involved and share their views by completing the survey, we’re particularly interested in people with cancer/cancer patients.
If you have any questions, please contact Chris Barnes at firstname.lastname@example.org